We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Motus GI Holdings Inc (MOTS) USD0.0001

Sell:$0.26 Buy:$0.27 Change: $0.0176 (6.25%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Sell:$0.26
Buy:$0.27
Change: $0.0176 (6.25%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Sell:$0.26
Buy:$0.27
Change: $0.0176 (6.25%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Motus GI Holdings, Inc. is a medical technology company. The Company, through its subsidiaries in the United States and Israel, is engaged in providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. It has developed the Pure-Vu System, a medical device that helps to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. Its wholly owned subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.

Contact details

Address:
1301 E Broward Blvd Fl 3
FORT LAUDERDALE
33301-2152
United States
Telephone:
+1 (786) 4591831
Website:
https://www.motusgi.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MOTS
ISIN:
US62014P1084
Market cap:
$14.54 million
Shares in issue:
55.06 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Mark Pomeranz
    President, Chief Operating Officer, Director
  • Timothy Moran
    Chief Executive Officer, Director
  • Andrew Taylor
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.